Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07125898

Decoding Central Defects in Dystrophinopathies From Diagnostic to Remediation

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The study aims to identify a genotype/phenotype correlation by analyzing more finely the neurodevelopmental disorders in DMD patients.

Detailed description

We propose a unique longitudinal study in which DMD children aged 5-12 years old will first be engaged in a deep evaluation of a range of cognitive, behavioral, physiological and neural functions (identification of biomarkers based on ERG) and an eligible subgroup of patients will then enter a second study phase (last 2 years) aimed at developing targeted cognitive remediation strategies: 1. Deep evaluation with research of correlation between DMD patients' genotype and neurological/neuropsychological phenotype: - the nature and severity of the cognitive/executive/behavioral deficits, - the retinal/visual alterations, - functional brain imaging. 2. Targeted cognitive remediation strategies in the same patients, to alleviate the identified neuropsychological and behavioral disturbances. We will place a particular focus on the socio-cognitive and executive weaknesse.

Conditions

Timeline

Start date
2025-10-01
Primary completion
2027-10-01
Completion
2029-04-01
First posted
2025-08-15
Last updated
2025-08-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07125898. Inclusion in this directory is not an endorsement.

Decoding Central Defects in Dystrophinopathies From Diagnostic to Remediation (NCT07125898) · Clinical Trials Directory